SLQT vs. CLOV, ROOT, IGIC, YB, HIPO, BOW, HRTG, WDH, TIPT, and ACIC
Should you be buying SelectQuote stock or one of its competitors? The main competitors of SelectQuote include Clover Health Investments (CLOV), Root (ROOT), International General Insurance (IGIC), Yuanbao (YB), Hippo (HIPO), Bowhead Specialty (BOW), Heritage Insurance (HRTG), Waterdrop (WDH), Tiptree Financial (TIPT), and American Coastal Insurance (ACIC). These companies are all part of the "insurance" industry.
SelectQuote vs. Its Competitors
SelectQuote (NYSE:SLQT) and Clover Health Investments (NASDAQ:CLOV) are both small-cap insurance companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation.
SelectQuote has a net margin of 3.12% compared to Clover Health Investments' net margin of -2.68%. SelectQuote's return on equity of 6.35% beat Clover Health Investments' return on equity.
In the previous week, Clover Health Investments had 2 more articles in the media than SelectQuote. MarketBeat recorded 5 mentions for Clover Health Investments and 3 mentions for SelectQuote. Clover Health Investments' average media sentiment score of 0.40 beat SelectQuote's score of 0.35 indicating that Clover Health Investments is being referred to more favorably in the news media.
SelectQuote has a beta of 1.3, indicating that its stock price is 30% more volatile than the S&P 500. Comparatively, Clover Health Investments has a beta of 2.1, indicating that its stock price is 110% more volatile than the S&P 500.
SelectQuote has higher revenue and earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than SelectQuote, indicating that it is currently the more affordable of the two stocks.
34.6% of SelectQuote shares are owned by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are owned by institutional investors. 13.1% of SelectQuote shares are owned by insiders. Comparatively, 24.1% of Clover Health Investments shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
SelectQuote currently has a consensus price target of $4.38, indicating a potential upside of 137.00%. Clover Health Investments has a consensus price target of $4.37, indicating a potential upside of 61.13%. Given SelectQuote's higher possible upside, research analysts clearly believe SelectQuote is more favorable than Clover Health Investments.
Summary
SelectQuote beats Clover Health Investments on 10 of the 17 factors compared between the two stocks.
Get SelectQuote News Delivered to You Automatically
Sign up to receive the latest news and ratings for SLQT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding SLQT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
SelectQuote Competitors List
Related Companies and Tools
This page (NYSE:SLQT) was last updated on 10/20/2025 by MarketBeat.com Staff
